Study Group: Physicians who Treat Diabetes (Germany)(?)
Council Members in this Study Group: 26
This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.
Request a survey with this Study Group
Related Study Groups
| Study Group Name | Members |
|---|---|
| Physicians (Germany) | 1146 |
| Diabetologist Endocrinologists (Germany) | 35 |
| Endocrinologists who Specialize in Diabetes in Europe | 152 |
| Obesity Endocrinologists in Europe | 30 |
| Exubera Prescribers | 113 |
| Cardiologists (EU) | 822 |
| Lipid Management Cardiologists (Europe) | 20 |
GLG NewsSMAnalyses by this Study Group's Leading Experts(?)
Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
Life-extending effect of Byetta ? | 08-13-2008
Analysis of:
Lilly Diabetes Drug Shows a Life-Extending Promise | www.nytimes.com
Author: GLG Expert Contributor
In a small subgroup of type-2-diabetes patients in the ACCORD trial which had been treated with Byetta (825 of 10 000) a lowerde death rate was found as compared to the whole group. This is a hypothesis-generating finding. Fewer hypoglycemias, even mild ones, may be an exüplanation for this...
A new gliptin - what is the difference to sita- and vildagliptin? | 07-29-2008
Analysis of:
AstraZeneca and Bristol-Myers Squibb Submit New Drug Application in the United States and Marketing Authorisation Application in Europe for ONGLYZA™ (Saxagliptin) for the Treatment of Type 2 Diabetes | www.astrazeneca.com
Author: GLG Expert Contributor
As the member of an Advisory board for a gliptin ande not familiar with details on saxagliptin it would be interested to know what makes the difference to the gliptins already on the US and EU market. How is the DPP-4-specifity? Only for DDP-4 or also somewhat for DPP-9? Or other DPP´s ? What´s on with...
Most Common Company Types:
- Academic Medical Center/Hospital or Clinic
- Office Based Private Practice or Clinic
- Private/For-Profit Healthcare Research Entity
- Consultancy, Healthcare-Focused
- Contract Research Organization, Independent/Small
- Contract Research Organization, Large
- Professional or Industry Association*
Most Common Job Types:
- Physician - Attending Physician
- Physician - Division Head
- Physician - Director
- Owner
- Research Scientist
- President
- Chief Operating Officer
- Consultant
- Director
- Medical Director
- Partner
GLG's 750+ Clients Include:
40 of the leading 50
global mutual funds
global mutual funds
15 of the leading 20
global banks
global banks
8 of the leading 10
private equity firms
private equity firms
90%+ client subscription renewal rate